ecancermedicalscience

Short Communication

Essential considerations in the investigation of associations between insulin and cancer risk using prescription databases

11 Dec 2009
P Boyle, I Ford, JFR Robertson, C La Vecchia, P Boffetta, P Autier

Studies of disease outcomes using administrative databases have identified a number of problems with the approach that suggest the need for a high level of expertise in their conduct. This is particularly true in the case of the investigation of the role of different insulins and the risk of cancer, which poses particular issues addressed below.

Related Articles

Nikhil Bathija, Rohit Mahajan, Anil Kumar Goel, Siva Ranjani, Mounika Sirimalla, Gourav Kaushal, Sapna Marcus, Shilpa Jain, Madhur Verma, Deep Shikha, Korukonda Vinod Kumar, Jyoti Sharma
Pavan Raju Kola, Amith Paruchuri, Nimisha Preman, Hemavathi Baskarane, Vishakha Hooda, Aparna Sharma, Ishaan Gupta, Saran Kumar, Shilpi Minocha, Pranay Tanwar, Mohit Kumar Divakar, Atul Batra
Loreto Fernández-González, Rodrigo Lagos, Piero Bettoli, Loreto Moreira, Jaime Sapag, David Kissane
Jaden Paltoo, Danusha Vinoraj, Elizaveta Klekovkina, Alyssa Tilly, John Bosco, John Lule, Akosua Agyemang, Maria Chikasema, Selena Kleber, Mary Goombs, Iddi Matovu, Craig Sinclair, Wendy G. Lichtenthal, Lesley Chalklin, Eve Namisango, Gary Rodin
Pallavi Rajput, Vandita Pahwa, Charu Singh, Sankalp Sancheti, Ravikiran Pawar, Shikha Jain, Gurwinder Kaur, Kundan Rao, Navin Bansal, Rahat Brar, Tapas Dora, Ashish Gulia